Fresenius Medical Care and Humana Partner to Improve Health of Kidney Failure Patients Across the Nation
March 09 2017 - 7:30AM
Business Wire
Fresenius Medical Care North America (FMCNA), a division of
Fresenius Medical Care (NYSE: FMS), announced today that it is
joining forces with Humana Inc. (NYSE: HUM) in a new program
designed to improve care and health outcomes for Humana’s members
with end stage renal disease (ESRD).
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170309005310/en/
Under the program, FMCNA, operating through its Fresenius Health
Partners business, will implement its proprietary care coordination
model to enhance the ability of these patients to obtain the health
care services they need to address their illness and improve their
quality of life.
Each patient will be supported by a collaborative team of local
nephrologists and clinicians working in partnership with the Care
Navigation Unit (CNU), FMCNA’s group of specialized nurses and
service coordinators who provide 24/7 support and care coordination
services. By focusing on the unique physical and emotional needs of
each patient, the CNU foresees issues before they arise and helps
patients, their families and their providers respond as they
happen.
“Through this partnership, we will positively impact the overall
medical care of Humana’s ESRD members who receive treatment within
our dialysis centers, and it’s our responsibility to ensure they
can access the care they need, when they need it,” said William
McKinney, President of FMCNA’s Integrated Care Group. “Ultimately,
we believe our coordinated approach to patient care will be a
natural extension of Humana’s existing platform and can boost their
patients’ health outcomes.”
“We look forward to applying our expertise in improving care
coordination for chronic illnesses to the benefit of Humana’s
members with ESRD, and to partnering with an organization that
shares this dedication to clinical excellence,” said Bill Valle,
FMCNA’s chief executive officer.
“We strive to help our chronically-ill members achieve their
optimal health,” said Dr. Mark Steffen, Medical Director with
Humana. “By working with Fresenius Medical Care to bring this
highly specialized program to Humana’s medically-fragile members
who need it most, we can help them experience more coordinated care
that meets their needs and improves both health outcomes and
quality of life as they move along their health care journey.”
FMCNA’s CNU has been quickly gaining national recognition for
its ability to drive positive change in health outcomes for
chronically ill populations.
About Fresenius Medical Care North AmericaFresenius
Medical Care North America is the premier health care company
focused on providing the highest quality care to people with renal
and other chronic conditions. Through its industry-leading network
of dialysis facilities, outpatient cardiac and vascular labs, and
urgent care centers, as well as the country’s largest practice of
hospitalist and post-acute providers, Fresenius Medical Care
provides coordinated health care services at pivotal care points
for hundreds of thousands of chronically ill customers throughout
the continent. As the world’s largest fully integrated renal
company, it offers specialty pharmacy and laboratory services, and
manufactures and distributes the most comprehensive line of
dialysis equipment, disposable products, and renal pharmaceuticals.
For more information, visit the FMCNA website at www.fmcna.com.
About Fresenius Health
PartnersFresenius Health Partners is the insurance component of
Fresenius Medical Care North America specializing in intensive care
coordination and disease management services for individuals with
Chronic Kidney Disease or End Stage Renal Disease. Launched in 2006
and rapidly emerging as the recognized leader in providing
comprehensive healthcare coverage for renal patients, Fresenius
Health Partners works with government payors, private health plans
and accountable care organizations to improve the health and
outcomes of renal patients while at the same time reducing the
total cost of their care. For more information on Fresenius Health
Partners’ programs, including the Fresenius Seamless Care ESCOs,
visit www.freseniushealthpartners.com.
About Humana:Humana Inc.,
headquartered in Louisville, Ky., is a leading health and
well-being company focused on making it easy for people to achieve
their best health with clinical excellence through coordinated
care. The company’s strategy integrates care delivery, the member
experience, and clinical and consumer insights to encourage
engagement, behavior change, proactive clinical outreach and
wellness for the millions of people we serve across the
country.
More information regarding Humana is available to investors via
the Investor Relations page of the company’s web site at
www.humana.com, including copies of:
• Annual reports to stockholders
• Securities and Exchange Commission filings
• Most recent investor conference presentations
• Quarterly earnings news releases
• Calendar of events
• Corporate Governance information
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170309005310/en/
Fresenius Medical Care North AmericaJon Stone,
781-392-4680Jonathan.d.stone@fmc-na.comorHumana Inc.Marina Renneke,
602-760-1758mrenneke@humana.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From May 2024 to Jun 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jun 2023 to Jun 2024